Dr. Christina Cress Lindenmeyer, MD

Dr. Lindenmeyer practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Lindenmeyer's NPI, 1780974667, was assigned on April 13, 2011. Dr. Lindenmeyer holds Ohio license 35.133114.

Dr. Lindenmeyer's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Lindenmeyer's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Lindenmeyer is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Lindenmeyer to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Lindenmeyer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lindenmeyer practices, 7 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Lindenmeyer's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Lindenmeyer is licensed in Ohio.

CMS data shows 271 Medicare services from Dr. Lindenmeyer across 6 procedure codes in 2024, for 153 Medicare patients. Medicare paid $17,208 for them.

CMS counts 153 Medicare patients who saw Dr. Lindenmeyer in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lindenmeyer's median patient age at 59, with 56% women.

In 2024, Dr. Lindenmeyer wrote 723 Medicare Part D claims for 121 patients. 84% of them were for generic drugs. CMS names the drug for 639 of them, across 20 drugs with 11 or more claims each, at $313,309 in total drug cost. In 2023, CMS named 844 claims across 22 drugs.

Dr. Lindenmeyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lindenmeyer as offering telehealth. CMS counts 24 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lindenmeyer, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Lindenmeyer, published from 2014 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Liver Cirrhosis, Liver Transplantation and Hepatorenal Syndrome. Dr. Lindenmeyer has published most often in Clin Liver Dis (Hoboken). Dr. Lindenmeyer's most frequent co-authors are Aanchal Kapoor, MD, William D. Carey, MD and Vedha Sanghi, MD.

CMS Open Payments shows 10 general payments to Dr. Lindenmeyer from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 96% of the total. Merck Sharp & Dohme Corporation paid the most, $4,385.